A long-awaited generic version of Truvada, used for both HIV treatment and PrEP, went on the market Friday, October 2. But the wholesale cost of the new pill from Teva Pharmaceuticals – about $1,455 – ...
Efavirenz 400mg, lamivudine 300mg, tenofovir disoproxil fumarate 300mg; tabs. Efavirenz (EFV) is an NNRTI of HIV-1. EFV activity is mediated predominantly by noncompetitive inhibition of HIV-1 reverse ...
With World Acquired Immunodeficiency Syndrome Day approaching Dec. 1, it’s important to learn about some of the prevention methods and efforts. Besides correctly and consistently using safer sex ...
SAN FRANCISCO (MarketWatch) -- Gilead Sciences Inc. and Merck & Co. after Friday's closing bell said they have inked an agreement for the distribution of their once-daily HIV treatment, Atripla, to ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
NEW YORK, Dec 1 (Reuters) - The chief executive of Gilead Sciences Inc. said on Friday that the launch of its triple-combination AIDS drug, Atripla, is "going quite well" and that the arrival of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results